Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) has a higher risk of death within 5 years of being diagnosed than the other forms of breast cancer. It is the second leading cause of death due to cancer among women. Currently, however, no diagnostic blood-based biomarker exists to identify the early stages of T...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Jee Min, Jung, Yongsik, Kim, Young Pil, Song, Jinsue, Kim, Soyeon, Kim, Ji Young, Kwon, Mira, Yoon, Jung Hyun, Kim, Myo-Deok, Lee, Jun-kyoung, Chung, Da-Yoon, Lee, Seo Yun, Kang, Jooseong, Kang, Ho Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880970/
https://www.ncbi.nlm.nih.gov/pubmed/29628988
http://dx.doi.org/10.4048/jbc.2018.21.1.87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880970/
https://www.ncbi.nlm.nih.gov/pubmed/29628988
http://dx.doi.org/10.4048/jbc.2018.21.1.87

Ejemplares similares